» Articles » PMID: 23558749

LncRNA Loc285194 is a P53-regulated Tumor Suppressor

Overview
Specialty Biochemistry
Date 2013 Apr 6
PMID 23558749
Citations 242
Authors
Affiliations
Soon will be listed here.
Abstract

Protein-coding genes account for only a small part of the human genome, whereas the vast majority of transcripts make up the non-coding RNAs including long non-coding RNAs (lncRNAs). Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis. LncRNA loc285194 was previously shown to be within a tumor suppressor unit in osteosarcoma and to suppress tumor cell growth. However, it is unknown regarding the regulation of loc285194. Moreover, the underlying mechanism by which loc285194 functions as a potential tumor suppressor is elusive. In this study, we show that loc285194 is a p53 transcription target; ectopic expression of loc285194 inhibits tumor cell growth both in vitro and in vivo. Through deletion analysis, we identify an active region responsible for tumor cell growth inhibition within exon 4, which harbors two miR-211 binding sites. Importantly, this loc285194-mediated growth inhibition is in part due to specific suppression of miR-211. We further demonstrate a reciprocal repression between loc285194 and miR-211; in contrast to loc285194, miR-211 promotes cell growth. Finally, we detect downregulation of loc285194 in colon cancer specimens by quantitative PCR arrays and in situ hybridization of tissue microarrays. Together, these results suggest that loc285194 is a p53-regulated tumor suppressor, which acts in part through repression of miR-211.

Citing Articles

Pivotal Role of miRNA-lncRNA Interactions in Human Diseases.

Pooresmaeil F, Azadi S, Hasannejad-Asl B, Takamoli S, Bolhassani A Mol Biotechnol. 2024; .

PMID: 39673006 DOI: 10.1007/s12033-024-01343-y.


Bibliometric analysis and visualisation of research hotspots and frontiers on omics in osteosarcoma.

Wang X, Cao X, Dai Z, Dai Z J Cancer Res Clin Oncol. 2024; 150(8):393.

PMID: 39172141 PMC: 11341630. DOI: 10.1007/s00432-024-05898-w.


LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review.

Hu S, Han X, Liu G, Wang S Front Endocrinol (Lausanne). 2024; 15:1415722.

PMID: 39015175 PMC: 11249743. DOI: 10.3389/fendo.2024.1415722.


lncRNAs regulate cell stemness in physiology and pathology during differentiation and development.

Lu J, Xu L, Wang Y, Guan B Am J Stem Cells. 2024; 13(2):59-74.

PMID: 38765805 PMC: 11101988. DOI: 10.62347/VHVU7361.


Association of Genetic Polymorphisms in Long Noncoding RNA HOTTIP with Risk of Idiopathic Recurrent Spontaneous Abortion.

Mirinejad S, Salimi S, Sargazi S, Heidari Nia M, Sheervalilou R, Majidpour M Biochem Genet. 2023; 62(4):2884-2906.

PMID: 38038774 DOI: 10.1007/s10528-023-10571-x.


References
1.
Karginov F, Conaco C, Xuan Z, Schmidt B, Parker J, Mandel G . A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A. 2007; 104(49):19291-6. PMC: 2148283. DOI: 10.1073/pnas.0709971104. View

2.
Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

3.
Wapinski O, Chang H . Long noncoding RNAs and human disease. Trends Cell Biol. 2011; 21(6):354-61. DOI: 10.1016/j.tcb.2011.04.001. View

4.
Huarte M, Guttman M, Feldser D, Garber M, Koziol M, Kenzelmann-Broz D . A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010; 142(3):409-19. PMC: 2956184. DOI: 10.1016/j.cell.2010.06.040. View

5.
Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M . A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011; 147(2):358-69. PMC: 3234495. DOI: 10.1016/j.cell.2011.09.028. View